Instructions for authors
Acta Neuropsychiatrica, the official Journal of Scandinavian College of Neuropsychopharmacology, is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal’s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health.
The steps of translation that are within the scope include: 1) fundamental discovery, 2) bench to bedside, 3) clinical trials, 4) translation to clinical guidelines, 5) health policy and usage, and 6) global health.
Research covering molecular biology, genetics, pharmacology, imaging and epidemiology is welcome as it contributes to enhancing the field.
Acta Neuropsychiatrica welcomes full-length Original Research Articles, Short Communications, Commentaries, Review Articles, Method/protocol Articles, Perspectives, and Research Letters. Debate is encouraged in the form of Letters to the Editor.
All articles published in Acta Neuropsychiatrica undergo peer review.
In submitting a manuscript to Acta Neuropsychiatrica, all authors must agree to abide by all relevant COPE policies, including its Guidelines for Responsible Conduct Regarding Scientific Communication. Manuscripts with multiple authors are reviewed with the explicit understanding that all authors have seen and approve of the submitted version and agree to abide to the policies.
POLICY ON ETHICS
It is expected that authors submitting papers to Acta Neuropsychiatrica will have conducted their work in accordance with relevant ethical standards. Procedures involving experiments on human subjects should be in accordance with the ethical standards of the Committee on Human Experimentation of the institution in which the experiments were done or in accordance with the Helsinki Declaration of 1975. Procedures involving experimentation on animals should be done in accordance with the guidelines of the country/institution in which the experiments were done.
Acta Neuropsychiatrica recognizes its responsibility to ensure that questions of scientific misconduct or dishonesty in research are adequately pursued. Should scientific misconduct or dishonesty be suspected or alleged, Acta Neuropsychiatrica follows the recommended procedures outlined by the Committee on Publication Ethics (COPE).
POLICY ON PREPUBLICATION
Acta Neuropsychiatrica does not consider manuscripts that have been previously published.
Posting to a preprint server such as bioRxiv, Authorea, Open Science Framework, etc. is not considered prior publication. Posting a manuscript to a preprint server while under review is allowed up until the point of acceptance. Abstracts, theses, posters, or manuscripts that have been posted on the Internet for the purpose of receiving commentary from the community are not considered prior publication. Online posting is typically done at a prepublication repository that has been designed for that purpose but posting on an institutional website or other Internet location is acceptable.
It is essential that any material submitted to Acta Neuropsychiatrica be original to the authors and that any copyright, license, or permission is obtained prior to submission. See Policy on Copyright for more details.
POLICY ON MOLECULAR DATA
Protein and nucleic acid sequences: Newly determined nucleotide or protein sequences must be deposited in GenBank, EMBL-EBI, or the DDBJ Center. Accession numbers must be reported in the manuscript and data must be available upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.
Genomic and proteomic data: Authors of papers that include functional genomics data such as microarray, ChIP-sequencing, RNA-Seq, or other high-throughput data are required to deposit the data in a MIAME-compliant database such as GEO, ArrayExpress, or CYBEX, and to provide accession numbers. Data must be publicly accessible upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.
Authors of papers that include proteomics data should comply with the guidelines developed by Molecular and Cellular Proteomics (https://www.mcponline.org/page/content/mass-spec-guidelines).
POLICY ON COMPUTER CODE AND SOFTWARE
Computational models: We recommend that new computer code be deposited in a suitable repository such as GitHub, ModelDB, BioModels, CellML, or Visiome. Studies using custom code central to the conclusions should include a statement in the Materials and Methods section, under the heading “Code Accessibility”, indicating whether the code can be accessed and how, including any accession numbers or restrictions; code should also be cited in the references. Code should be available upon acceptance and publication of the manuscript.
Software: If new software or a new algorithm is used for data analysis, authors are encouraged to deposit it in an appropriate public repository. A statement should be included in the Materials and Methods section, under the heading “Software Accessibility”, indicating whether the software or algorithm can be accessed and how, including any accession numbers or restrictions.
POLICY ON IMAGE MANIPULATION
Original data: The editors reserve the right to request any original, unprocessed data from authors at any stage in the submission, review, or publication process, including after publication. Failure to provide requested information may result in publication delays, rejection, or revocation of acceptance.
Image manipulation: All images in manuscripts accepted for publication will be screened for any indication of manipulation that is inconsistent with the following guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance.
No specific feature within an image may be enhanced, obscured, moved, removed, or introduced.
Constructing figures using images taken from different parts of the same gel or from different gels is discouraged. When this is necessary, it must be made explicit by the arrangement of the figure (e.g., using dividing lines) and in the text of the figure legend.
Recordings obtained at different time points or from different sites must not be spliced together to give the appearance of a continuous record. Authors must make it clear in the figure legend how many different recordings are illustrated.
Adjustments to images or recordings are acceptable if they are applied uniformly to all portions of the image or recording, and if they do not obscure, eliminate, or misrepresent information present in the original, including the background. Adjustments involving filtering or scaling (e.g., brightness, contrast, or color balance) must be applied to every pixel in the image or applied uniformly to an entire recording. Nonlinear adjustments (e.g., changes to gamma settings) or deleting portions of a recording (e.g. leak subtraction or stimulus artifacts) must be disclosed in the figure legend.
The minimum resolution for images is 300 dpi. Vector-format is preferred.
At the time of acceptance, authors will be required to submit uncropped images of complete gels for comparison to the prepared figures. If original data cannot be produced, the acceptance of the manuscript may be revoked.
POLICY CONCERNING AVAILABILITY OF MATERIALS AND DATA
Authors must agree to make freely available to colleagues in academic research any clones of cells, nucleic acids, antibodies, etc. that were used in the research reported and that are not available from commercial suppliers.
Authors should, when possible, honor requests for access to any form of published data for appropriate scientific use. The editors reserve the right to request any original data from authors at any stage in the review or publication process, including after publication. Failure to provide requested information may result in publication delays or revocation of acceptance
Submission
All manuscript submissions to Acta Neuropsychiatrica must be completed electronically through the Acta Neuropsychiatrica ScholarOne Manuscripts (formerly known as Manuscript Central) website: http://mc.manuscriptcentral.com/acn
Submissions will be considered provided that papers are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content and agree to the submission of the manuscript to the Journal.
Acta Neuropsychiatrica employs a plagiarism detection system for all submitted papers. By submitting your manuscript to this journal you accept that your manuscript will be screened for plagiarism against previously published works.
Review process
All manuscripts submitted to the journal will first be editorially reviewed by the Editor-in-Chief, who will then assign the papers to a subject-specific Associate Editor.
The authors should suggest three to five potential peer reviewers in their submission. The contact details of suggested reviewers should be institutional email addresses where possible, or contain information which will help the editor to verify the identity of the reviewer (for example ORCiD or a main reference stated in the cover letter). Should there be any non-preferred reviewers, a proper explanation must be given in the cover letter.
The Associate Editor will then assign at least two independent referees to review each paper. Based on the referee reports received along with input from the Associate Editor, the Editor-in-Chief will decide to either reject, request revisions or accept the manuscript.
Once a revised version is received, the Editors and referees will evaluate the revised manuscript. Authors will then be notified of whether their paper has been accepted or rejected for publication in the Journal.
All manuscripts accepted for publication are subject to editing by the publisher for presentation, style and grammar. The Editor-in-Chief's decision is final.
Categories of papers
Acta Neuropsychiatrica accepts the following contributions:
Original research articles
Original articles report the results of original research and are intended for full- scale basic or clinical studies including large controlled trials. Translational work is encouraged, but not required. Original articles should not exceed 6,500 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered for unusually large or complex studies).
Short communications
This category is for 'fast-breaking' new work, which is of great potential interest and can be succinctly presented. Papers in this category may contain up to 2,500 words (not including references, figures and tables) and should include a maximum of 25 references, up to 2 illustrations (figures or tables), an abstract of up to 150 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search).
Commentaries
Commentaries focus attention on scientific issues in the field of the journal, and should highlight, discuss and amplify these issues. Commentaries may contain up to 5,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). Commentaries are invited by the Editor-in-Chief.
Method/Protocol articles
Acta Neuropsychiatrica will publish a limited number of Method/Protocol articles, which focus on protocols and on novel methods providing significant improvements and extensions to already established research areas. Method/Protocol articles may be invited by the Editors but can also be submitted. Method/Protocol articles may contain up to 6,000 words (not including refs, figs and tables) and should include an abstract of up to 250 words. and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered if justified by the scope of the paper).
Review articles
Acta Neuropsychiatrica will publish a limited number of scholarly, comprehensive reviews that summarize and critically evaluate research in the field addressed and identify future implications. Reviews may be invited by the Editors but can also be submitted. Reviews may contain up to 10,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered if justified by the scope of the Review).
Perspectives articles
Acta Neuropsychiatrica will publish a limited number of Perspective articles that critically perspective research in the field addressed and describe future potentials. Perspectives may be invited by the Editors but can also be submitted. Perspectives may contain up to 10,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in strict accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search). (Exceptions to the length limitation will be considered if justified by the scope of the Perspectives).
Protocol articles
Acta Neuropsychiatrica will publish a limited number of Method/Protocol articles, which focus on protocols and on novel methods providing significant improvements and extensions to already established research areas. Method/Protocol articles may be invited by the Editors but can also be submitted. Method/Protocol articles may contain up to 6,000 words (not including references, figures and tables) and should include an abstract of up to 250 words and 5 keywords in accordance with Medical Subject Headings (https://meshb.nlm.nih.gov/search).
Debate papers
Letters to the Editor are welcomed to the Acta Neuropsychiatrica debate section, especially if they relate to ongoing debates or comment on recent publications in the Journal. A maximum of 5 references can be included in papers published in the Debate Section.
……
更多详情：
https://www.cambridge.org/core/journals/acta-neuropsychiatrica/information/instructions-contributors
